Trial intelligence / Profile preview

Mepivacaine vs Low-Dose Bupivacaine for TKA/THA Spinal Anesthesia

NCT03838874Phase 3Completed

Sponsor
Mayo Clinic
Start
Feb 2019
Primary completion
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of mepivacaine in knee osteoarthritis (OA), hip osteoarthritis, sponsored by Mayo Clinic. Started Feb 2019; status: completed.

02

Drugs

mepivacaine
03

Conditions

knee osteoarthritis (OA)hip osteoarthritis

Beyond the preview

Go deeper on NCT03838874.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03838874.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call